Jacqueline Corrigan-Curay, JD, MD

Silver Spring, MD

Director, Office of Medical Policy, U.S. Food and Drug Administration

Represented: Policy Makers
Term ended August 2022

Jacqueline Corrigan-Curay, JD, MD, serves as director of the Office of Medical Policy in the Center for Drug Evaluation and Research at the Food and Drug Administration (FDA). She leads the development, coordination, and implementation of medical policy programs and strategic initiatives, including policy development on real-world evidence, drug labeling, prescription drug promotion, clinical trial oversight, and innovative trial design. She works collaboratively with other Center program areas, FDA centers, and stakeholders on enhancing policies to improve drug development and regulatory review processes.

Prior to joining FDA, Corrigan-Curay served as supervisory medical officer with the Immediate Office of the Director, National Heart, Lung and Blood Institute at the National Institutes of Health (NIH), where she focused on developing policies and procedures to enhance the clinical trial enterprise. She also served as the director of the Office of Biotechnology Activities, Office of Science Policy at NIH, where she was executive secretary of the NIH Recombinant DNA Advisory Committee. She has held positions as an attending physician with the Veterans Affairs Medical Center, a policy analyst with the Congressional Office of Technology Assessment, and a practicing attorney in Washington, DC.

Corrigan-Curay  served on the Advisory Panel on Clinical Trials from August 2019 to August 2022.